(Q61864912)
Statements
A Phase I/II Study of the Mitogen Activated Protein Kinase Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; HYD Sulfate) in Children With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) (English)
0 references
21 September 2011
0 references
10 September 2020
0 references
98
0 references
2 year
0 references
18 year
0 references